FSA Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$130K Buy
5,111
+4
+0.1% +$99 0.05% 75
2025
Q2
$124K Buy
5,107
+3
+0.1% +$70 0.05% 78
2025
Q1
$129K Buy
5,104
+203
+4% +$5.31K 0.05% 71
2024
Q4
$130K Buy
4,901
+3
+0.1% +$81 0.05% 70
2024
Q3
$142K Buy
+4,898
New +$143K 0.06% 73
2024
Q1
$130K Buy
4,692
+113
+2% +$3.14K 0.06% 73
2023
Q4
$132K Buy
+4,579
New +$138K 0.06% 70
2022
Q2
Sell
-3,452
Closed -$204K 40
2022
Q1
$204K Hold
3,452
0.12% 46
2021
Q4
$204K Buy
+3,452
New +$171K 0.12% 46
2021
Q1
Sell
-13,447
Closed -$495K 191
2020
Q4
$495K Sell
13,447
-574
-4% -$21.1K 0.25% 24
2020
Q3
$488K Sell
14,021
-456
-3% -$16K 0.31% 26
2020
Q2
$449K Sell
14,477
-214
-1% -$7.27K 0.31% 27
2020
Q1
$455K Hold
14,691
0.38% 26
2019
Q4
$546K Buy
+14,691
New +$523K 0.38% 24

Other funds holding PFE

FSA Wealth Management's PFE Position: Q3 2025 in Review

FSA Wealth Management increased its Pfizer (PFE) stake by 0.08% in Q3 2025, buying an estimated $99 and bringing the position to 5,111 shares worth $130K. The position accounts for 0.05% of the portfolio, ranked #75.

FSA Wealth Management first reported a position in PFE in Q4 2019 and has held it in 14 quarters since. The position peaked at $546K in Q4 2019. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • FSA Wealth Management held 5,111 shares of Pfizer worth $130K as of Q3 2025.
  • FSA Wealth Management bought 4 Pfizer shares in Q3 2025, an estimated $99.
  • Pfizer made up 0.05% of FSA Wealth Management's portfolio in Q3 2025, its #75 holding.
  • FSA Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 14 quarters since.
  • FSA Wealth Management's Pfizer position peaked at $546K in Q4 2019.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.